DNMT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.264200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.836600E-01
Normal-vs-Stage2
4.279200E-01
Normal-vs-Stage3
1.209190E-01
Normal-vs-Stage4
3.694000E-01
Stage1-vs-Stage2
3.862200E-01
Stage1-vs-Stage3
7.303800E-02
Stage1-vs-Stage4
8.515000E-01
Stage2-vs-Stage3
7.148500E-02
Stage2-vs-Stage4
9.557600E-01
Stage3-vs-Stage4
2.840600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.303600E-01
Normal-vs-AfricanAmerican
4.129600E-01
Normal-vs-Asian
4.148000E-01
Caucasian-vs-AfricanAmerican
8.704000E-01
Caucasian-vs-Asian
8.251200E-01
AfricanAmerican-vs-Asian
9.977000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.152000E-01
Normal-vs-Female
4.435600E-01
Male-vs-Female
5.367600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.357600E-01
Normal-vs-Age(41-60Yrs)
4.852600E-01
Normal-vs-Age(61-80Yrs)
3.948800E-01
Normal-vs-Age(81-100Yrs)
5.212800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.563100E-04
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.787600E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.922500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.822300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.542800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.391800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.836000E-02
Normal-vs-Daily Drinker
3.613000E-01
Normal-vs-Weekly Drinker
2.887600E-01
Normal-vs-Occasional Drinker
4.693200E-01
Normal-vs-Social Drinker
4.340000E-01
Non Drinker-vs-Daily Drinker
5.973400E-01
Non Drinker-vs-Weekly Drinker
5.127600E-01
Non Drinker-vs-Occasional Drinker
4.397600E-01
Non Drinker-vs-Social Drinker
7.108400E-01
Daily Drinker-vs-Weekly Drinker
3.512200E-01
Daily Drinker-vs-Occasional Drinker
1.303830E-01
Daily Drinker-vs-Social Drinker
3.010800E-01
Weekly Drinker-vs-Occasional Drinker
9.350400E-01
Weekly Drinker-vs-Social Drinker
7.371800E-01
Occasional Drinker-vs-Social Drinker
6.593800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.270800E-01
Normal-vs-Grade 2
8.438800E-01
Normal-vs-Grade 3
8.707200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.815800E-01
Grade 1-vs-Grade 3
3.037800E-01
Grade 1-vs-Grade 4
8.270800E-01
Grade 2-vs-Grade 3
3.196200E-01
Grade 2-vs-Grade 4
8.438800E-01
Grade 3-vs-Grade 4
8.707200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.127600E-01
Normal-vs-NonDiabetic
4.175400E-01
Diabetic-vs-NonDiabetic
8.923600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.897800E-01
Normal-vs-NoPancreatitis
4.135000E-01
Pancreatitis-vs-NoPancreatitis
5.633600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.632600E-01
Normal-vs-N1
4.152800E-01
N0-vs-N1
3.682600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.271200E-01
Normal-vs-TP53-NonMutant
3.997000E-01
TP53-Mutant-vs-TP53-NonMutant
6.823400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
